Skip to main content

Tumors With CDK4/6 Pathway Activation clinical trials at UC Davis
1 research study open to eligible people

  • LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

    open to eligible people ages 18 years and up

    The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or hematologic malignancies to warrant further study.

    Sacramento, California and other locations

Last updated: